Sellers beware, this isn’t a traditional bio stock that will require 3-4 years to get a product to market.
Here are several reasons to get you perked up for the weekend:
1. We’re ALREADY being prescribed in Australia and hopefully within the year will be in the US.
2. Our application is also less vigorous (see what I did there) than typical FDA approvals, we’re using a compound that is already approved and we’ve partnered with a company who manufacture approved nasal delivery products.
3. Within the next 6 months we will have several key catalysts that could double or even triple our market cap. I can imagine sales being limited only because we could not keep up with demand. Without even mentioning the potential TO.
I was fortunate purchase shares in June when people took profits after the trial results and was able to top up when the market had a mini correction earlier in August.
I might be late to this one, but I have been told, coming second is always better…
LTP Price at posting:
$1.80 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)